Collegium Pharmaceutical, Inc (COLL) balance sheet
COLLNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 13/3049% below fair value
$24.72−0.49 (-1.94%)
Close on Nov 20, 2026Market cap $804.78MP/E 19.9Yield –
Collegium Pharmaceutical, Inc balance sheet
Ratios
Latest available, balances at Jun 30, 2026
Profitability, TTM
- Gross margin
- 60.0%
- Operating margin
- 19.5%
- Net margin
- 5.9%
- Return on equity, FY2025
- 23.7%
Financial strength
- Current ratio
- 1.03
- Debt to equity
- –
- Debt to assets
- –
- Cash to current liabilities
- 21.9%
Valuation
- P/E ratio
- 19.9
- Price to sales
- 1.00
- Price to book
- 2.58
- Dividend yield
- –
See a number that looks wrong?